ANTHONY DIGIANDOMENICO
CIK 1083544 · Co-Founder · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$931.3K
Companies
7
Total Filings
73
Lifetime Open-Market Net
$1.55M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLIR | Director | — | $4.04 | — | $0 | 2 | 2026-07-02 |
| NDRA | Director | 136,589 | $4.46 | $609.2K | $100.0K | 6 | 2026-01-23 |
| MDBH | Co-Founder | 95,699 | $3.05 | $291.9K | $78.7K | 17 | 2025-08-08 |
| ENDRA Life Sciences Inc. (NDRAW) Delisted | Director | 382,012 | $0.03 | $11.5K | $16.9K | 17 | 2022-03-30 |
| Provention Bio, Inc. (PRVB) Delisted | Director | 520,712 | $24.98 | $13.01M | $1.08M | 18 | 2019-12-06 |
| CUE | Director | 1,000 | $30.25 | $30.2K | $275.5K | 7 | 2019-01-04 |
| Charlie's Holdings, Inc. (BZI.WS.B) Delisted | Director | — | — | — | $0 | 2 | 2008-08-22 |
Recent Filings · Page 4 of 8
73 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-23 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Exer (X) | +100,503 | $87.4K | EDGAR |
| 2020-06-09 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Buy (P) | +5,000 | $4.6K | EDGAR |
| 2020-05-29 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Buy (P) | +5,000 | $4.5K | EDGAR |
| 2020-05-26 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Buy (P) | +10,000 | $7.8K | EDGAR |
| 2020-04-13 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | +42,857 | $0 | EDGAR |
| 2020-01-06 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-11 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | +100,503 | $87.4K | EDGAR |
| 2019-12-06 | Provention Bio, Inc. (PRVB) Delisted | Other (J) | +342,000 | $0 | EDGAR |
| 2019-09-30 | Provention Bio, Inc. (PRVB) Delisted | Buy (P) | +30,000 | $204.9K | EDGAR |
| 2019-09-26 | Provention Bio, Inc. (PRVB) Delisted | Buy (P) | +5,000 | $42.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.